ACHP Supports the Biosimilar Red Tape Elimination Act

The Alliance of Community Health Plans (ACHP) urged Congress to pass the Biosimilar Red Tape Elimination Act, bipartisan legislation that would remove the outdated interchangeability designation for biosimilars and help lower drug costs for patients.

Loader Loading...
EAD Logo Taking too long?
Reload Reload document
| Open Open in new tab
icon-arrow
client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo
icon-arrow